Bone Morphogenetic Protein 13 Has Protumorigenic Effects on Hepatocellular Carcinoma Cells In Vitro
- PMID: 37446238
- PMCID: PMC10342282
- DOI: 10.3390/ijms241311059
Bone Morphogenetic Protein 13 Has Protumorigenic Effects on Hepatocellular Carcinoma Cells In Vitro
Abstract
Activated hepatic stellate cells (HSCs) play a key role in hepatic fibrosis and, thus, build the "soil" for hepatocarcinogenesis. Furthermore, HSCs are known to promote the progression of hepatocellular carcinoma (HCC), but the molecular mechanisms are only incompletely understood. Recently, we newly described the expression of bone morphogenetic protein 13 (BMP13) by HSCs in fibrotic liver tissue. In addition, BMP13 has mostly been studied in the context of cartilage and bone repair, but not in liver disease or cancer. Thus, we aimed to analyze the expression and function of BMP13 in HCC. Expression analyses revealed high BMP13-expression in activated human HSCs, but not in human HCC-cell-lines. Furthermore, analysis of human HCC tissues showed a significant correlation between BMP13 and α-smooth muscle actin (α-SMA), and immunofluorescence staining confirmed the co-localization of BMP13 and α-SMA, indicating activated HSCs as the cellular source of BMP13 in HCC. Stimulation of HCC cells with recombinant BMP13 increased the expression of the inhibitors of differentiation 1 (ID1) and 2 (ID2), which are known targets of BMP-signaling and cell-cycle promotors. In line with this, BMP13-stimulation caused an induced SMAD 1/5/9 and extracellular signal-regulated kinase (ERK) phosphorylation, as well as reduced expression of cyclin-dependent kinase inhibitors 1A (CDKN1A) and 2A (CDKN2A). Furthermore, stimulation with recombinant BMP13 led to increased proliferation and colony size formation of HCC cells in clonogenicity assays. The protumorigenic effects of BMP13 on HCC cells were almost completely abrogated by the small molecule dorsomorphin 1 (DMH1), which selectively blocks the intracellular kinase domain of ALK2 and ALK3, indicating that BMP13 acts via these BMP type I receptors on HCC cells. In summary, this study newly identifies stroma-derived BMP13 as a potential new tumor promotor in HCC and indicates this secreted growth-factor as a possible novel therapeutic target in HCC.
Keywords: BMP13; hepatic stellate cells; hepatocellular carcinoma.
Conflict of interest statement
The Human Tissue and Cell Research-Services GmbH is the part of the HTCR Foundation that is in charge for the technical isolation of primary cells out of human specimens. The primary liver cells used in the present study have been provided by the HTCR Foundation for free/without any charges. The authors declare no conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10342282/bin/ijms-24-11059-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10342282/bin/ijms-24-11059-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10342282/bin/ijms-24-11059-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10342282/bin/ijms-24-11059-g004.gif)
Similar articles
-
Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies.Int J Mol Sci. 2022 Dec 4;23(23):15292. doi: 10.3390/ijms232315292. Int J Mol Sci. 2022. PMID: 36499616 Free PMC article. Review.
-
Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis.J Cell Biochem. 2022 Oct;123(10):1544-1552. doi: 10.1002/jcb.30248. Epub 2022 Apr 20. J Cell Biochem. 2022. PMID: 35442524
-
Hepatic Stellate Cell: A Potential Target for Hepatocellular Carcinoma.Curr Mol Pharmacol. 2020;13(4):261-272. doi: 10.2174/1874467213666200224102820. Curr Mol Pharmacol. 2020. PMID: 32091349 Review.
-
Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma.BMC Cancer. 2019 Dec 5;19(1):1192. doi: 10.1186/s12885-019-6362-1. BMC Cancer. 2019. PMID: 31805888 Free PMC article.
-
Cluster of differentiation 147 is a key molecule during hepatocellular carcinoma cell-hepatic stellate cell cross-talk in the rat liver.Mol Med Rep. 2015 Jul;12(1):111-8. doi: 10.3892/mmr.2015.3429. Epub 2015 Mar 4. Mol Med Rep. 2015. PMID: 25738354 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous